CLGN Annual CFO
-$2.76 M
+$10.94 M+79.83%
31 December 2023
Summary:
As of January 23, 2025, CLGN annual cash flow from operations is -$2.76 million, with the most recent change of +$10.94 million (+79.83%) on December 31, 2023. During the last 3 years, it has risen by +$1.69 million (+37.92%). CLGN annual CFO is now -210.48% below its all-time high of $2.50 million, reached on December 31, 2021.CLGN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLGN Quarterly CFO
-$3.45 M
+$480.00 K+12.22%
30 September 2024
Summary:
As of January 23, 2025, CLGN quarterly cash flow from operations is -$3.45 million, with the most recent change of +$480.00 thousand (+12.22%) on September 30, 2024. Over the past year, it has dropped by -$10.22 million (-150.89%). CLGN quarterly CFO is now -131.01% below its all-time high of $11.12 million, reached on March 1, 2021.CLGN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLGN TTM CFO
-$12.97 M
-$10.22 M-371.78%
30 September 2024
Summary:
As of January 23, 2025, CLGN TTM cash flow from operations is -$12.97 million, with the most recent change of -$10.22 million (-371.78%) on September 30, 2024. Over the past year, it has dropped by -$9.21 million (-244.69%). CLGN TTM CFO is now -240.23% below its all-time high of $9.25 million, reached on March 1, 2021.CLGN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLGN Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +79.8% | -150.9% | -244.7% |
| 3 y3 years | +37.9% | -150.9% | -244.7% |
| 5 y5 years | -127.0% | -150.9% | -244.7% |
CLGN Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -210.5% | +79.8% | -150.9% | +12.8% | -618.8% | +6.9% |
| 5 y | 5-year | -210.5% | +79.8% | -131.0% | +12.8% | -240.2% | +6.9% |
| alltime | all time | -210.5% | +79.8% | -131.0% | +12.8% | -240.2% | +6.9% |
CollPlant Biotechnologies Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.45 M(-12.2%) | -$12.97 M(+371.8%) |
| June 2024 | - | -$3.93 M(+20.8%) | -$2.75 M(+7.2%) |
| Mar 2024 | - | -$3.25 M(+38.7%) | -$2.57 M(-7.1%) |
| Dec 2023 | -$2.76 M(-79.8%) | -$2.35 M(-134.6%) | -$2.76 M(-26.6%) |
| Sept 2023 | - | $6.78 M(-281.0%) | -$3.76 M(-72.6%) |
| June 2023 | - | -$3.74 M(+8.5%) | -$13.72 M(-1.5%) |
| Mar 2023 | - | -$3.45 M(+3.1%) | -$13.94 M(+1.7%) |
| Dec 2022 | -$13.70 M(-647.7%) | -$3.35 M(+5.1%) | -$13.70 M(+7.3%) |
| Sept 2022 | - | -$3.19 M(-19.5%) | -$12.77 M(+3.0%) |
| June 2022 | - | -$3.96 M(+23.1%) | -$12.40 M(+4.9%) |
| Mar 2022 | - | -$3.21 M(+32.7%) | -$11.83 M(-573.0%) |
| Dec 2021 | $2.50 M(-156.2%) | - | - |
| Dec 2021 | - | -$2.42 M(-14.1%) | $2.50 M(-24.8%) |
| Sept 2021 | - | -$2.82 M(-16.7%) | $3.32 M(-56.4%) |
| June 2021 | - | -$3.38 M(-130.4%) | $7.63 M(-17.5%) |
| Mar 2021 | - | $11.12 M(-796.2%) | $9.25 M(-307.9%) |
| Dec 2020 | -$4.45 M(-22.0%) | - | - |
| Dec 2020 | - | -$1.60 M(-207.3%) | -$4.45 M(-0.9%) |
| Sept 2020 | - | $1.49 M(-184.7%) | -$4.49 M(-38.6%) |
| June 2020 | - | -$1.76 M(-32.0%) | -$7.32 M(-0.1%) |
| Mar 2020 | - | -$2.58 M(+57.7%) | -$7.33 M(+28.5%) |
| Dec 2019 | -$5.70 M | - | - |
| Dec 2019 | - | -$1.64 M(+22.4%) | -$5.70 M(+560.8%) |
| Sept 2019 | - | -$1.34 M(-24.2%) | -$863.00 K(+42.2%) |
| June 2019 | - | -$1.77 M(+84.2%) | -$607.00 K(-16.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$959.00 K(-130.0%) | -$723.00 K(-40.6%) |
| Dec 2018 | -$1.22 M(-75.5%) | - | - |
| Dec 2018 | - | $3.20 M(-395.6%) | -$1.22 M(-78.9%) |
| Sept 2018 | - | -$1.08 M(-42.5%) | -$5.77 M(+3.0%) |
| June 2018 | - | -$1.88 M(+29.5%) | -$5.60 M(+17.4%) |
| Mar 2018 | - | -$1.45 M(+7.4%) | -$4.77 M(-3.9%) |
| Dec 2017 | -$4.97 M(-1.3%) | - | - |
| Dec 2017 | - | -$1.35 M(+48.1%) | -$4.97 M(+7.3%) |
| Sept 2017 | - | -$913.60 K(-13.2%) | -$4.63 M(+2.1%) |
| June 2017 | - | -$1.05 M(-36.1%) | -$4.53 M(-7.2%) |
| Mar 2017 | - | -$1.65 M(+62.0%) | -$4.88 M(-3.0%) |
| Dec 2016 | -$5.03 M(+35.5%) | - | - |
| Dec 2016 | - | -$1.02 M(+24.5%) | -$5.03 M(+3.9%) |
| Sept 2016 | - | -$816.50 K(-41.8%) | -$4.84 M(+5.6%) |
| June 2016 | - | -$1.40 M(-21.9%) | -$4.59 M(-0.2%) |
| Mar 2016 | - | -$1.80 M(+116.7%) | -$4.60 M(+23.8%) |
| Dec 2015 | -$3.71 M(+11.6%) | - | - |
| Dec 2015 | - | -$829.10 K(+48.2%) | -$3.71 M(+105.1%) |
| Sept 2015 | - | -$559.30 K(-60.4%) | -$1.81 M(+44.7%) |
| June 2015 | - | -$1.41 M(+55.1%) | -$1.25 M(-179.8%) |
| Mar 2015 | - | -$911.60 K(-184.9%) | $1.57 M(-36.8%) |
| Dec 2014 | -$3.33 M(-12.5%) | - | - |
| Dec 2014 | - | $1.07 M(-23.7%) | $2.48 M(+76.3%) |
| June 2014 | - | $1.41 M | $1.41 M |
| Dec 2013 | -$3.80 M(-1.5%) | - | - |
| Dec 2012 | -$3.86 M | - | - |
FAQ
- What is CollPlant Biotechnologies annual cash flow from operations?
- What is the all time high annual CFO for CollPlant Biotechnologies?
- What is CollPlant Biotechnologies annual CFO year-on-year change?
- What is CollPlant Biotechnologies quarterly cash flow from operations?
- What is the all time high quarterly CFO for CollPlant Biotechnologies?
- What is CollPlant Biotechnologies quarterly CFO year-on-year change?
- What is CollPlant Biotechnologies TTM cash flow from operations?
- What is the all time high TTM CFO for CollPlant Biotechnologies?
- What is CollPlant Biotechnologies TTM CFO year-on-year change?
What is CollPlant Biotechnologies annual cash flow from operations?
The current annual CFO of CLGN is -$2.76 M
What is the all time high annual CFO for CollPlant Biotechnologies?
CollPlant Biotechnologies all-time high annual cash flow from operations is $2.50 M
What is CollPlant Biotechnologies annual CFO year-on-year change?
Over the past year, CLGN annual cash flow from operations has changed by +$10.94 M (+79.83%)
What is CollPlant Biotechnologies quarterly cash flow from operations?
The current quarterly CFO of CLGN is -$3.45 M
What is the all time high quarterly CFO for CollPlant Biotechnologies?
CollPlant Biotechnologies all-time high quarterly cash flow from operations is $11.12 M
What is CollPlant Biotechnologies quarterly CFO year-on-year change?
Over the past year, CLGN quarterly cash flow from operations has changed by -$10.22 M (-150.89%)
What is CollPlant Biotechnologies TTM cash flow from operations?
The current TTM CFO of CLGN is -$12.97 M
What is the all time high TTM CFO for CollPlant Biotechnologies?
CollPlant Biotechnologies all-time high TTM cash flow from operations is $9.25 M
What is CollPlant Biotechnologies TTM CFO year-on-year change?
Over the past year, CLGN TTM cash flow from operations has changed by -$9.21 M (-244.69%)